Paclitaxel (Taxol) and Docetaxel (Taxotere): active chemotherapeutic agents in lung cancer
Open Access
- 1 April 1995
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 12, S163-S172
- https://doi.org/10.1016/0169-5002(95)00432-z
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Dose‐related cutaneous toxicities with etoposideCancer, 1993
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Phase I Trial of Taxotere: Five-Day ScheduleJNCI Journal of the National Cancer Institute, 1992
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- The Chemistry of Taxol, a Clinically Useful Anticancer AgentJournal of Natural Products, 1990
- Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analoguesTetrahedron, 1989
- Highly efficient, practical approach to natural taxolJournal of the American Chemical Society, 1988
- Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly.The Journal of cell biology, 1983